Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 7F7DM | IM / RL |
Large Local Reaction to DTaP Vaccine Approximately 48 hours after receiving her fourth dose of the DTaP vaccine (Infanrix brand) in the leg, the patient developed a large local reaction measuring about 110 millimeters at its largest dimension. The reaction was initially painful yesterday but is not currently causing discomfort or interfering with her activities. The mother notes the reaction may be mildly itchy. The mother has documented the reaction in the immunization record. Severe local reaction to DTaP vaccine (measured at 110mm), not associated with significant functional impairment or ongoing pain; child can continue normal activities. - Symptomatic management: pain medication as needed for discomfort, topical diphenhydramine for pruritus if present. - Reaction may still get a little bigger but is not expected to spread much more after today. - Instructed to document the reaction in the Immunization Registry.
bee sting to left foot/toe
no known health conditions
no known medications or supplements
NKDA, no known allergies to food
none
Dtap Infanrix- whole body hives per parent